Krystal Biotech, Inc.
$284.57
$2.38(-0.83%)
Krystal Biotech, Inc.
KRYS
$284.57
$2.38(-0.83%)
Krystal Biotech, Inc.
KRYS
NASDAQ
$284.57
$2.38(-0.83%)
Chart
Upcoming Earnings
Next report date
Aug 3, 2026
Report period
Q3 2026
EPS Estimate
$1.73
Revenue Estimate
$124.69M
Key stats
52-Week Range$284.57
$122.80
$303.00
Market capitalization
$8.38BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
37.59Basic EPS (TTM)
$7.08Net income (TTM)
$204.83MRevenue (TTM)
$389.13MAvg. volume
285.70KBeta (1Y)
0.50Employees
275Market capitalization
$8.38BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
37.59Basic EPS (TTM)
$7.08Net income (TTM)
$204.83MRevenue (TTM)
$389.13MAvg. volume
285.70KBeta (1Y)
0.50Employees
275Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Krystal Biotech, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Krish S. Krishnan
Website
www.krystalbio.comHeadquarters
2100 Wharton Street, Pittsburgh, PA, 15203
IPO Date
2017-09-20
Identifiers
ISIN
US5011471027Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy...
Related Stocks
$74.93
1D:
-1.9%
1Y:
436.0%
US04280A1007Healthcare
Mkt Cap
$10.49B
P/E Ratio TTM
51.8
Revenue TTM
$1.09B
Beta
1.27
Earnings TTM
$202.27M
Dividend Yield TTM
0.00%
$55.64
1D:
-4.9%
1Y:
62.3%
US92243G1085Healthcare
Mkt Cap
$8.03B
P/E Ratio TTM
-10.1
Revenue TTM
$0.00
Beta
1.39
Earnings TTM
$-766.63M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate